ATHX

Athersys, Inc. [ATHX] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

ATHX Stock Summary

Top ATHX Correlated Resources

ATHX


Top 10 Correlated ETFs

ATHX


Top 10 Correlated Stocks

ATHX


In the News

04:19 08 Dec 2022 ATHX

Athersys, Inc. (ATHX) Q3 2022 Earnings Call Transcript

Athersys, Inc. (NASDAQ:ATHX ) Q3 2022 Earnings Conference Call November 15, 2022 11:00 AM ET Company Participants Ellen Gurley – Corporate Communications and Investor Relations Dan Camardo – Chief Executive Officer Kasey Rosado – Interim Chief Financial Officer Conference Call Participants Operator Good morning. My name is Devon and I will be your conference operator today.

08:30 08 Dec 2022 ATHX

Athersys to Present at Challenges and Opportunities for Mesenchymal Stem Cells Digital Conference and Participate in A.G.P.'s Biotech Conference

CLEVELAND--( BUSINESS WIRE )--Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today its participation in two November conferences, the Challenges and Opportunities for Mesenchymal Stem Cells digital conference being held November 17-18, 2022 and A.G.P.'s Biotech Conference on November 30, 2022.

08:30 08 Dec 2022 ATHX

Athersys to Host Third Quarter Financial Results Call

CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (Nasdaq: ATHX) will be hosting a conference call on Thursday, November 10, 2022, at 4:30 PM Eastern Time to review its third quarter 2022 financial results.

11:43 08 Dec 2022 ATHX

Athersys: Is Big Pharma Sleeping At The Wheel?

Due to an extended downtrend in Athersys stock price due largely to a declining cash position, Athersys currently trades at a market cap near $24 million. The current valuation is miniscule when compared to valuations of other stem cell companies, especially when considering the strong IP portfolio of Athersys.

09:25 08 Dec 2022 ATHX

Athersys to Present at 2022 Cell & Gene Meeting on the Mesa Conference and Attend 14th World Stroke Congress in October

CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today their participation in two October conferences, the 2022 Cell & Gene Meeting on the Mesa on October 11-13, 2022 and the 14th World Stroke Congress on October 26-29, 2022. Dr. Robert W. Mays, Executive Vice President and Head of Regenerative Medicine & Neuroscience, will present live at the 2022 Cell & Gene Mee

12:33 08 Dec 2022 ATHX

Athersys to Host Business Update Conference Call on October 6th

CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, announced today it will host a business update conference call on October 6, 2022 at 4:00 pm Eastern Time. Dan Camardo, Chief Executive Officer, Maia Hansen, Chief Operating Officer, Kasey Rosado, Interim Chief Financial Officer, and Robert “Willie” Mays, Executive Vice President Regenerative Medicine and Head of Neuroscience, will provi

06:00 08 Dec 2022 ATHX

Hot Penny Stocks to Buy This Week? 3 to Watch Now

Which penny stocks are you watching today? The post Hot Penny Stocks to Buy This Week?

03:32 08 Dec 2022 ATHX

Best Penny Stocks To Buy: 3 High Volume Stocks To Watch Today

High volume penny stocks to watch before next week. The post Best Penny Stocks To Buy: 3 High Volume Stocks To Watch Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

07:00 08 Dec 2022 ATHX

The Three Best Anti-Aging Stocks to Buy in September

Anti-aging stocks have not proven immune to poor market conditions that have plagued the broader biotech industry. The biotech industry remains hampered by the same bleak economic conditions as those affecting growth companies.

11:37 08 Dec 2022 ATHX

ATHX, PETS: The Top 5 Short Squeeze Stocks to Watch This Week

Source: g0d4ather / Shutterstock.com We're starting off another week with a deep dive into the short squeeze stocks to watch! Short squeeze stocks have been popular with traders in recent months as they search for the next big breakout.

ATHX Financial details

Company Rating
Neutral
Market Cap
10.93M
Income
-45.86M
Revenue
5.29M
Book val./share
-1.4
Cash/share
1.16
Dividend
-
Dividend %
-
Employees
104
Optionable
No
Shortable
Yes
Earnings
15 Nov 2022
P/E
-1.59
Forward P/E
-
PEG
-0.02
P/S
1.27
P/B
-0.41
P/C
0.56
P/FCF
-0.1
Quick Ratio
0.37
Current Ratio
0.54
Debt / Equity
-0.49
LT Debt / Equity
-0.49
-
-
EPS (TTM)
-4.64
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-72.81%
Revenue Q/Q
-97.19%
EPS Q/Q
-
-
-
-
-
SMA20
-50%
SMA50
-50%
SMA100
-80%
Inst Own
19.28%
Inst Trans
2.12%
ROA
-129%
ROE
1571%
ROC
26.69%
Gross Margin
44%
Oper. Margin
-1608%
Profit Margin
-867%
Payout
-
Shs Outstand
17.21M
Shs Float
12.3M
-
-
-
-
Target Price
5
52W Range
0.5-33.25
52W High
-
52W Low
-
RSI
33
Rel Volume
0.23
Avg Volume
1.78M
Volume
413.85K
Perf Week
9.26%
Perf Month
-70.44%
Perf Quarter
-90%
Perf Half Y
-91.33%
-
-
-
-
Beta
-0.577076
-
-
Volatility
0.03%, 0.82%
Prev Close
14.41%
Price
0.6503
Change
18.24%

ATHX Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2021-12-31

Metric History 2017-12-312018-12-312019-12-312020-12-31 2021-12-31
Revenue per share
0.030.180.040.010
Net income per share
-0.29-0.18-0.29-0.420
Operating cash flow per share
-0.21-0.1-0.23-0.330
Free cash flow per share
-0.22-0.11-0.24-0.340
Cash per share
0.260.370.230.270.2
Book value per share
0.210.320.150.170.09
Tangible book value per share
0.210.320.150.170.09
Share holders equity per share
0.210.320.150.170.09
Interest debt per share
00000.05
Market cap
5.01B5.36B5.27B9.09B4.03B
Enterprise value
4.99B5.31B5.24B9.04B4B
P/E ratio
-155.53-220.86-118.24-115.440
Price to sales ratio
1.35K220.79935.816.31K730.98K
POCF ratio
-208.78-401.73-149.22-147.10
PFCF ratio
-206.33-360.38-146.82-144.390
P/B Ratio
214.51124.39226.52289.92246.24
PTB ratio
214.51124.39226.52289.92246.24
EV to sales
1.34K218.69929.596.28K725.97K
Enterprise value over EBITDA
-157.97-226.74-119.32-116.09-45.98K
EV to operating cash flow
-207.55-397.91-148.23-146.270
EV to free cash flow
-205.12-356.95-145.84-143.570
Earnings yield
-0.010-0.01-0.010
Free cash flow yield
00-0.01-0.010
Debt to equity
00000.53
Debt to assets
0.30.30.440.470.73
Net debt to EBITDA
0.932.180.80.66317.5
Current ratio
3.093.742.92.381.54
Interest coverage
00000
Income quality
0.740.550.790.780
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
2.280.432.0211.030
Research and developement to revenue
7.511.596.9343.7512.89
Intangibles to total assets
00000
Capex to operating cash flow
0.010.110.020.020
Capex to revenue
-0.08-0.06-0.1-0.810
Capex to depreciation
-0.42-1.79-0.83-1.310
Stock based compensation to revenue
0.820.160.865.120
Graham number
1.161.121.011.260
ROIC
-1.42-0.54-1.58-2.13-2.87
Return on tangible assets
-0.96-0.39-1.07-1.320
Graham Net
0.180.260.110.12-0.03
Working capital
21.11M42.37M24.33M31.61M16.17M
Tangible asset value
00000
Net current asset value
20.97M39.23M18.78M26.21M2.21M
Invested capital
00000.6
Average receivables
414K2.54M525.5K89K751.5K
Average payables
8.76M11.1M11.58M13.04M14.41M
Average inventory
00000
Days sales outstanding
72.7474.9862.3322.5693.6K
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
5.024.875.8616.180
Payables turnover
00000
Inventory turnover
00000
ROE
-1.38-0.56-1.92-2.510
Capex per share
0-0.010-0.010

Quarterly Fundamentals Overview

Last date of statement is 2022-09-30 for Q3

Metric History 2021-09-302021-12-312022-03-312022-06-30 2022-09-30
Revenue per share
000.30.220.01
Net income per share
00-2.27-2.280
Operating cash flow per share
-0.160-2.06-1.58-2.58
Free cash flow per share
-0.160-2.08-1.74-2.44
Cash per share
0.220.162.231.291.16
Book value per share
0.130.070.03-1.13-1.4
Tangible book value per share
0.130.070.03-1.13-1.4
Share holders equity per share
0.130.070.03-1.13-1.4
Interest debt per share
0.090.040.970.890.76
Market cap
7.62B5.33B148.96M67.49M21.93M
Enterprise value
7.59B5.3B136.68M63.37M17.1M
P/E ratio
00-1.68-0.710
Price to sales ratio
1.59M-1.31M51.1529.14337.41
POCF ratio
-207.390-7.39-4.11-0.72
PFCF ratio
-211.090-7.32-3.73-0.76
P/B Ratio
259.7325.61485.21-5.75-1.32
PTB ratio
259.7325.61485.21-5.75-1.32
EV to sales
1.58M-1.3M46.9427.36263.13
Enterprise value over EBITDA
-481.78K81.2-6.22-2.75-1.08
EV to operating cash flow
-206.580-6.78-3.86-0.56
EV to free cash flow
-210.260-6.72-3.51-0.59
Earnings yield
00-0.15-0.350
Free cash flow yield
00-0.14-0.27-1.32
Debt to equity
0.60.5327.65-0.71-0.49
Debt to assets
0.590.730.991.331.47
Net debt to EBITDA
1.88K-0.420.560.180.3
Current ratio
2.11.5410.640.54
Interest coverage
00000
Income quality
000.910.70
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.7601.412.2357.49
Research and developement to revenue
3.588.64K7.198.98191.14
Intangibles to total assets
00000
Capex to operating cash flow
000.010.10
Capex to revenue
00-0.06-0.710
Capex to depreciation
00-0.75-2.650
Stock based compensation to revenue
1.11K00.480.8452.48
Graham number
001.277.610
ROIC
-0.37-0.71-1.6-12.235.25
Return on tangible assets
00-0.49-0.670
Graham Net
0.04-0.02-1.98-2.97-3.2
Working capital
30.46M16.17M136K-11.85M-17.98M
Tangible asset value
00000
Net current asset value
15.4M2.21M-13.55M-25.57M-31.41M
Invested capital
0.680.631.01-0.79-0.54
Average receivables
3.5M2.5M4.12M3.59M2.13M
Average payables
20.99M20.34M21.4M24.9M27.04M
Average inventory
00000
Days sales outstanding
63.86K-31.27K143.5139.66913.85
Days payables outstanding
00000
Days of inventory on hand
00000
Receivables turnover
000.630.640.1
Payables turnover
00000
Inventory turnover
00000
ROE
00-72.362.010
Capex per share
00-0.02-0.160

ATHX Frequently Asked Questions

What is Athersys, Inc. stock symbol ?

Athersys, Inc. is a US stock , located in Cleveland of Ohio and trading under the symbol ATHX

What is Athersys, Inc. stock quote today ?

Athersys, Inc. stock price is $0.6503 today.

Is Athersys, Inc. stock public?

Yes, Athersys, Inc. is a publicly traded company.

Something similar

Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap